Dr Matthew Partridge
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
Latest articles by Dr Matthew Partridge
-
The style and glamour of the Goodwood Revival
Reviews Matthew Partridge talks to a motor-sports legend about the appeal of the Goodwood Revival car festival.
By Dr Matthew Partridge Published
Reviews -
Ensign Group: profiting from US private care
Tips Nursing and care-home specialist Ensign Group should thrive as Americans age. Matthew Partridge picks the best way to play it.
By Dr Matthew Partridge Published
Tips -
Royal Mail will deliver for investors – here's how to play it
Tips Royal Mail Group has found its feet in the past 18 months and looks cheap. Matthew Partridge looks at how to trade the shares.
By Dr Matthew Partridge Published
Tips -
How you can profit from the power of the grey pound
Cover Story Higher life expectancy and surging asset prices have proved a boon for the baby-boomer generation, which has accumulated vast wealth. Younger generations can benefit too, says Matthew Partridge.
By Dr Matthew Partridge Published
Cover Story -
Sony A7c: a pro-level camera at an affordable price
Reviews The Sony A7c will give you high-quality photographs without breaking the bank, says Matthew Partridge
By Dr Matthew Partridge Published
Reviews -
Edinburgh beyond the Fringe
Reviews The Edinburgh festivals, and the city itself, remain well worth a visit, says Matthew Partridge
By Dr Matthew Partridge Published
Reviews -
Trading: how to cash in on America's hot housing market
Tips Homebuilder Pultegroup is perfectly placed to cash in on the US housing boom. Matthew Partridge explains how to play it.
By Dr Matthew Partridge Published
Tips -
AstraZeneca’s Covid troubles could see it pull out of making vaccines
News AstraZeneca has suffered a series of setbacks with its Covid-19 jab and may exit the inoculation subsector altogether. Matthew Partridge reports
By Dr Matthew Partridge Published
News -
HSBC’s profits surge – but will the share price?
News Pre-tax profits at banking giant HSBC rose from $1.1bn last year to $5.1bn in 2021, but the share price remains depressed.
By Dr Matthew Partridge Published
News -
How to profit from pampered pets beyond the pandemic
Cover Story Covid-19 has greatly boosted ownership. But the market had been expanding for years, and demographic, cultural and medical trends all point to long-term growth. Matthew Partridge reports
By Dr Matthew Partridge Published
Cover Story -
Marlboro Man stubs it out as Philip Morris CEO says “ban cigarettes”
News The boss of tobacco giant Philip Morris has called for a cigarette ban in the UK. But the industry isn’t about to disappear.
By Dr Matthew Partridge Published
News -
Tesla is starting to motor as profits roll in
News Sales at electric-car maker Tesla reached almost $12bn in the second quarter of 2021, nearly double the level of a year ago.
By Dr Matthew Partridge Published
News -
Tate & Lyle takeover proves sweet for private equity
News Tate & Lyle has proved an enticing morsel for private-equity group KPS Capital Partners, which is buying part of its operations. Matthew Partridge reports
By Dr Matthew Partridge Published
News -
Trading: a cheap broker set to bounce
Tips Interdealer broker TP ICAP is cheap, expanding steadily and restoring its dividend. Matthew Partridge explains the best way to play it.
By Dr Matthew Partridge Published
Tips -
Pandemic plunderers target Daily Mail
News Share in Daily Mail and General Trust jumped by 10% this week after rumours that the newspaper business would be taken private.
By Dr Matthew Partridge Published
News -
Nvidia's Arm Holdings takeover gets vote of support
News Three top chipmakers have expressed support for Nvidia's controversial $40bn takeover of Arm Holdings. But it could still fail. Matthew Partridge reports
By Dr Matthew Partridge Published
News -
Betting on politics: the odds on Keir Starmer leaving
Tips Labour's recent by-election win has eased the pressure on Kier Starmer. But there's still plenty of action in the betting markets, as Matthew Partridge reports.
By Dr Matthew Partridge Published
Tips -
Unsportsmanlike conduct at JD Group
News JD Group shareholders have staged a revolt over executive pay.
By Dr Matthew Partridge Published
News -
Private equity's supermarket sweep
News The private-equity battle for Wm Morrison is intensifying now that it has accepted a bid from Fortress Investment. Matthew Partridge reports
By Dr Matthew Partridge Published
News -
Shake-up at GSK won’t placate investors
News GSK has launched a radical shakeup of its operations, but that's unlikely to satisfy investors unhappy with the drugmaker's perennial underperformance.
By Dr Matthew Partridge Published
News -
Morrisons takeover bid: supermarket is an attractive target for private-equity buyers
News A private-equity group has made an offer for Morrisons, Britain’s fourth-largest supermarket. Other bids are likely to emerge. Matthew Partridge reports.
By Dr Matthew Partridge Last updated
News -
Soho House IPO: celebrities’ hangout hits the market
News Soho House has filed for an initial public offering in New York that values the group at more than $3bn.
By Dr Matthew Partridge Last updated
News -
Investing in stem cells, the building blocks of the body
Cover Story Stem cells have always been tomorrow’s technology. But it looks as though their time has finally come – and they will transform the treatment of disease and drug development, says Matthew Partridge
By Dr Matthew Partridge Last updated
Cover Story -
How to short AMC shares
Tips US cinema chain AMC is the latest meme stock and is now absurdly overvalued, says Matthew Partridge, Here's how to play it.
By Dr Matthew Partridge Last updated
Tips